Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-08-30
2011-08-30
Mertz, Prema (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007210, C435S007240
Reexamination Certificate
active
08008027
ABSTRACT:
The present invention provides nucleotide and amino acid sequences that identify and encode a novel expressed chemokine (ADEC) from inflamed adenoid tissue. The present invention also provides for antisense molecules to the nucleotide sequences which encode ADEC, expression vectors for the production of purified ADEC, antibodies capable of binding specifically to ADEC, hybridization probes or oligonucleotides for the detection of ADEC-encoding nucleotide sequences, genetically engineered host cells for the expression of ADEC, diagnostic tests for inflammation or disease based on ADEC-encoding nucleic acid molecules or antibodies capable of binding specifically to ADEC.
REFERENCES:
patent: 3817837 (1974-06-01), Rubenstein
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3939350 (1976-02-01), Kronick et al.
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4277437 (1981-07-01), Maggio
patent: 4366241 (1982-12-01), Tom et al.
patent: 4657760 (1987-04-01), Kung et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4800195 (1989-01-01), Burgess et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5011912 (1991-04-01), Hopp et al.
patent: 5094941 (1992-03-01), Hart
patent: 5126434 (1992-06-01), Osawa et al.
patent: 5206344 (1993-04-01), Katre et al.
patent: 5225212 (1993-07-01), Martin et al.
patent: 5633149 (1997-05-01), Guegler et al.
patent: 5844084 (1998-12-01), Guegler et al.
patent: 6071701 (2000-06-01), Guegler et al.
patent: 6692920 (2004-02-01), Guegler et al.
Goodman et al., “Molecular Cloning of Porcine Alveolar Macrophage-Derived Neutrophil Chemotactic Factors I and II: Identification of Porcine IL-8 and Another Intercrine-α Protein†′‡”,Biochemistry, vol. 31, No. 43, Nov. 3, 1992 (pp. 10483-10490).
Harlow et al., “Human Hybridomas”,Antibodies, A Laboratory Manual, 1988 (p. 241).
Lin et al., “Regulation of Interleukin-8 Expression in Porcine Alveolar Macrophages by Bacterial Lipopolysaccharide”,The Journal of Biological Chemistry, vol. 269, No. 1, Jan. 7, 1994 (pp. 77-85).
Seow et al., “Cloning, sequencing, expression and inflammatory activity in skin of ovine interleukin-8”,Immunology and Cell Biology, vol. 72, Issue 5, Oct. 1994 (pp. 398-405).
BLAST results for alignment of SEQ ID No. 2 and MCP-4, at National Center for Biotechnology Information database (2 pp.), (May 7, 2006).
BLAST results for alignment of SEQ ID No. 1 and the gene for MCP-4, at National Center for Biotechnology Information database (2 pp.), (May 7, 2006).
Huse et al., “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda”,Science, vol. 246, Dec. 8, 1989 (pp. 1275-1281).
Orlandi et al., “Cloning immunoglobulin variable domains for expression by the polymerase chain reaction”,Proc. Natl. Acad. Sci., vol. 86, May 1989 (pp. 3833-3837).
Sambrook et al., Molecular Cloning: A Laboratory Manual, 2ndEd, Cold Spring Harbor, N.Y. (4 pp.), (1989).
“Synopsis of Application of Written Description Guidelines” (66 pp), (1999).
Winter et al., “Man-made antibodies”,Nature, vol. 349, Jan. 24, 1991 (pp. 293-299).
Harlow and Lane (1988) Antibodies, A Laboratory Manual. Cold Spring Harbor Laboratory, Chap. 5, p. 76.
Rieger et al., Glossary of Genetics and Cytogenetics, Fourth Edition, Springer-Verlag, pp. 16-19, (1976).
Mikayama et al., Proc. Natl. Acad. Sci. USA vol. 90, pp. 10056-10060, (1993).
Voet et al., Biochemistry, John Wiley & Sons, Inc., pp. 126-128 and 228-234, (1990).
Vilcek, J., et al., Immunology of Cytokines,The Cytokine HandbookAcademic Press, Copyright 1991, Chap. 1, pp. 1-17.
Shaw, A.R., “Molecular Biology of Cytokines” The Cytokine Handbook, Academic Press, Copyright 1991, Chapter 2, pp. 20-46.
Banchereau, J., “Interleukin-4” The Cytokine Handbook, Academic Press, Copyright 1991, Chapter 6, pp. 120-148.
Schall, T.J., “The Chemokines” The Chemokine Handbook, Academic Press, 1994, Sep. 19-20, Second Edition, pp. 180-272.
Uhlmann et al., “Antisense Oligonucleotides: a New Therapeutic Principle” Chemical Reviews 90(4):554-584 (1990).
Cotten et al., “Ribozyme Mediated Destruction of RNA in vivo” The EMBO Journal 8(12):3861-3866 (1989).
Ledley, F.D., “Clinical Consideration in the Design of Protocols for Somatic Gene Therapy” Human Gene Therapy 2:77-82 (1991).
Anderson, W.F., “Prospects for Human Gene Therapy” Science 226:401-409 (1984).
Opdenakker et al., “The Human MCP-3 Gene (SCYA7): Cloning, Sequence Analysis, and Assignment to the C-C Chemokine Gene Cluster on Chromosome 17g11.2-q12” Genomics 21:403-408 (1994).
Diamond et al., “Novel delayed-early and highly insulin-induced growth response genes. Indentification of WS, a potential regulator of alternative pre-mRNA splicing” Journal of Biol. Chem. 268(20):15185-15192 (1993).
Derynck et al., (1990) Biochemistry vol. 29, pp. 10225-10233.
Bork et al., Trends in Genetics, vol. 12, No. 10, pp. 425-427 (1996).
Doerks et al., Trends in Genetics, vol. 14, No. 6, pp. 248-250 (1998).
Brenner at al., Trends in Genetics, vol. 15, No. 8, pp. 132-133 (1999).
Schall, T. et'al., “Chemokines, leukocyte trafficking, and inflammation”, Current Opinion in Immunology 1994, 6:865-873.
Paul, “The Chemokine Family of Inflammatory Cytokines,”Fundamental Immunology, 3rdEd., pp. 822-826 (1993).
Walsh et al., “Preferential PCR Amplification of Alleles: Mechanisms and Solutions,”PCR Methods Appl., pp. 241-250 (1992).
Merrifield, “Solid Phase Peptide Synthesis,”J. Am. Chem. Soc., vol. 85, pp. 2149-2154 (1963).
Chirgwin et al., “Isolation of Biologically Active Ribonucleic Acid from Sources Enriched in Ribonuclease,”Biochemistry, vol. 18, pp. 5294-5299 (1979).
Maddox et al., “Elevated Serum Levels in Human Pregnancy of a Molecule Immunochemically Similar to Eosinophil Granule Major Basic Protein,”J. Exp. Med., vol. 158, pp. 1211-1226 (1983).
Faulk et al., “A 48-Well Micro Chemotaxis Assembly for Rapid and Accurate Measurement of Leukocyte Migration,”Journ. of Immun. Methods, vol. 33, pp. 239-247 (1980).
Grynkievicz et al., “A New Generation of Ca2+Indicators with Greatly Improved Fluorescence Properties,”J. Biol. Chem., vol. 260, No. 6, pp. 3440-3450 (1985).
McColl et al., “Uncoupling of Early Signal Transduction Events from Effector Function in Human Peripheral Blood Neutrophils in Response to Recombinant Macrophage Inflammatory Proteins-1α and -1β1,”J. Immunol., vol. 150, pp. 4550-4555 (1993).
Zachariae et al., “Properties of Monocyte Chemotactic and Activating Factor (MCAF) Purified from a Human Fibrosarcoma Cell Line,”J. Exp. Med., vol. 171, pp. 2177-2182 (1990).
Jiang et al., “Monocyte Chemoattractant Protein-1 Regulates Adhesion Molecule Expression and Cytokine Production in Human Monocytes,”J. Immunol., vol. 148, pp. 2423-2428 (1992).
Taub et al., “Preferential Migration of Activated CD4+and CD8+T Cells in Response to MIP-1α and MIP-1β,”Science, vol. 260, pp. 355-358 (1993).
Hodgson, “Data-Directed Drug Design,”Bio/Technology, vol. 9, pp. 19-21 (1991).
Braxton et al., “Incorporation of a Stabilizing Ca2+-Binding Loop into Subtilisin BPN',”Biochemistry, vol. 31, No. 34, pp. 7796-7801 (1992).
Athauda et al., “Entrapment and Inhibition of Human Immunodeficiency Virus Proteinase by α2-Macroglobulin and Structural Changes in the Inhibitor,”J. Biochem., vol. 113, pp. 742-746 (1993).
Bolton et al., “The Labelling of Proteins to High Specific Radioactivities by Conjugation to a125I-Containing Acylating Agent,”Biochem J., No. 133, pp. 529-539 (1973).
Hebert et al., “Scanning Mutagenesis of Interleukin-8 Identifies a Cluste
Guegler Karl J.
Hawkins Phillip R.
Seilhamer Jeffrey J.
Wilde Craig G.
Foley & Lardner LLP
Incyte Corporation
Mertz Prema
LandOfFree
Methods of screening for compounds that modulate the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of screening for compounds that modulate the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of screening for compounds that modulate the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2769387